Data / Drug companies / Prestige Brands Holdings, Inc.
Prestige Brands Holdings, Inc.: 20 products in the FDA NDC directory, labeler code 67172
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Prestige Brands Holdings, Inc. (labeler code 67172) lists 20 products in the FDA National Drug Code Directory, covering 10 finished drugs by generic name. By type: 20 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on June 20, 2026.
The request: Watch Prestige Brands Holdings, Inc. (FDA labeler code 67172): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 67172
- Products in commercial distribution
- 20
- Packages
- 22
- Finished drugs by generic name
- 10
- Prescription products
- 0
- Over the counter products
- 20
- Flagged as original packager
- 13 of 13 products that carry the flag
- Started marketing in the last 12 months
- 1
- Products with a marketing end date set
- 1
- Earliest marketing start
- August 1, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 20 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 20 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Phenol | 5 | 31 |
| Menthol and benzocaine | 4 | 1 |
| Menthol and benzocaine and dextromethorphan hydrobromide | 2 | 1 |
| Naphazoline hydrochloride and glycerin | 2 | 3 |
| Acetaminophen and diphenhydramine hydrochloride | 1 | 29 |
| Polyvinyl alcohol and povidone | 1 | 2 |
| Glycerin and naphazoline hydrochloride | 1 | 2 |
| Phenol and glycerin | 1 | 2 |
| Glycerin and naphazoline hydrochloride and zinc sulfate | 1 | 1 |
| Benzocaine | 1 | 110 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Lozenge | 7 | 35% |
| Spray | 6 | 30% |
| Liquid | 6 | 30% |
| Powder, for solution | 1 | 5% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Chloraseptic Nighttime Sore Throat Hot Relief | 67172-150 | Powder, for solution | Over the counter monograph drugs | June 20, 2026 |
| Chloraseptic Childrens Sore Throat Cherry | 67172-930 | Spray | Over the counter monograph drugs | June 20, 2024 |
| Clear Eyes Natural Tears | 67172-557 | Liquid | Over the counter monograph drugs | May 15, 2013 |
| Chloraseptic Warming Sore Throat | 67172-212 | Spray | Over the counter monograph drugs | July 1, 2012 |
| Chloraseptic Warming Sore Throat | 67172-017 | Lozenge | Over the counter monograph drugs | January 1, 2012 |
| Clear Eyes Redness Relief | 67172-797 | Liquid | Over the counter monograph drugs | April 27, 2011 |
| Clear Eyes Maximum Itchy Eye Relief | 67172-999 | Liquid | Over the counter monograph drugs | March 15, 2011 |
| Clear Eyes Triple Relief | 67172-898 | Liquid | Over the counter monograph drugs | March 15, 2011 |
| Clear Eyes Cooling Redness Relief | 67172-393 | Liquid | Over the counter monograph drugs | February 15, 2011 |
| Chloraseptic Sore Throat Max | 67172-937 | Spray | Over the counter monograph drugs | February 1, 2011 |
| Clear Eyes Maximum Redness Relief | 67172-696 | Liquid | Over the counter monograph drugs | September 1, 2010 |
| Chloraseptic Sore Throat Menthol | 67172-113 | Spray | Over the counter monograph drugs | September 1, 2010 |
| Chloraseptic Sore Throat Citrus | 67172-112 | Spray | Over the counter monograph drugs | September 1, 2010 |
| Chloraseptic Sore Throat Cherry | 67172-111 | Spray | Over the counter monograph drugs | September 1, 2010 |
| Chloraseptic max | 67172-114 | Lozenge | Over the counter monograph drugs | August 1, 2010 |
| Chloraspetic | 67172-023 | Lozenge | Over the counter monograph drugs | August 1, 2010 |
| Chloraseptic | 67172-022 | Lozenge | Over the counter monograph drugs | August 1, 2010 |
| Chloraseptic | 67172-021 | Lozenge | Over the counter monograph drugs | August 1, 2010 |
| Chloraseptic Total Sore Throat and Cough | 67172-016 | Lozenge | Over the counter monograph drugs | August 1, 2010 |
| Chloraseptic Total Sore Throat and Cough, Sugar Free | 67172-015 | Lozenge | Over the counter monograph drugs | August 1, 2010 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.